News & Resources

The Value of Continuous Insight Reports During Clinical Research

The Positive Impact Insight Reports Can Have on Clinical Research Plans

Effective clinical research requires a continuous stream of data, but gathering real-world data isn’t always easy. It can be particularly tricky for pharmaceutical manufacturer researchers to connect with practicing oncologists. Community oncologists have many demands on their time and may not be available to participate in clinical research when you need them most. However, their expertise and experiences are invaluable to researchers who rely on insight from practicing physicians.

Community physician insight reports and recommendations bridge that important knowledge gap. Aptitude Health CASES reports pull data from roundtable discussions where oncologists share information on how their treatment approaches, concerns, insights, and existing resource gaps impact treatment patterns. CASES reports also contain valuable information about regional issues that may affect cancer patients. Aptitude Health provides opportunities to obtain these important reports to life science partners on an ongoing basis through bundled and subscription opportunities. This results in a continuous stream of timely and relevant information to your team.

For years, Aptitude Health has organized regional roundtable discussion and insights-gathering events across the US.

CASES reports contain the key takeaways of these discussions, prescription trends, and expert analyses on the data and insights gathered. If your organization is engaged in clinical research focused on oncology and hematology, CASES reports provide critical information while saving you both time and money. They also allow your organization to refine your marketing and outreach efforts. Consider the following benefits of continuous insight reports.

Gaps in Understanding Delay Clinical Research
The clinical research process is costly and time-consuming. Pharma companies must streamline their research process to conserve funding. If your organization lacks essential data, your research projects may face costly delays. Gaps in research data can also prevent your researchers from producing accurate results.

Missing data or project delays harm your organization’s credibility. That’s why your organization needs access to high-quality, evidence-based data. With this essential information, your research team can keep the R&D process on track.

Purchasing a subscription to CASES provides round-the-clock insight from practicing oncologists. With continuous reporting, your team never misses important developments. Instead, your R&D staff remains current on industry trends.

Insight Reports Bridge the Gap Between Research and Real Life
Clinical researchers have extensive expertise, but even skilled researchers may overlook critical factors. A treatment that seems promising in a controlled clinical trial may prove impractical or undesirable in a real-world setting.

Continuous insight reports help bridge this gap. CASES reports deliver intelligence from top regional oncologists directly to your research team. Each report contains a wealth of data, including physician quotes, polls, and case studies, and details specific to your needs.

With a subscription or a report bundle, your team has ongoing access to observations from practicing physicians. This information informs future research activities.

Continuous Insight From Practicing Oncologists Guides R&D Efforts
During clinical research, your team needs access to a wide range of data. A few specific data points aren’t enough to support a complex project. Instead, your team needs comprehensive information that supports the entire research pipeline. CASES reports guide R&D from start to finish.

Before you invest in a new medication or treatment strategy, you need to know what treatments oncologists use. You also need to determine how well treatments work and what side effects practicing oncologists have observed. CASES reports provide detailed information on preferred treatment strategies. They also offer valuable insight into oncologists’ goals and priorities.

Demographics and regional care patterns can also affect a patient’s care, and these patterns are always changing. A CASES bundle or subscription keeps your team up to date. Continuous reports explore ongoing regional differences and experiences from diverse patient groups. Maintaining a subscription helps your organization monitor changes within the market.

Insight Reports Guide Marketing and Outreach Efforts
In the fight against cancer, communication is essential. Stakeholders must share current data and stay informed. Pharmaceutical manufacturers play an especially important role in the communication process. Your organization needs to stay abreast of market trends, and your research team needs to understand the factors that guide an oncologist’s treatment decisions.
CASES reports help your organization determine whether further outreach is necessary. Each report highlights concerns from practicing oncologists. Polls and other key takeaways help your organization learn how clinicians are using available treatments.

This information helps your organization identify areas of concern. Quotes from clinicians can also offer insight into the oncologists’ mindset. CASES reports help deepen your understanding of oncologists’ preferences and goals.

Your organization can then tailor its marketing and outreach efforts. If oncologists seem unclear about the mechanism of a new treatment or doubt its effectiveness, your organization can supply relevant data. The more targeted your outreach efforts, the better your chances of communicating your message. Your CASES bundle or subscription delivers valuable insight throughout the year, so you can continually refine your marketing strategy.

Understanding CASES Reports
CASES reports help your organization understand the therapeutic approaches used in regional settings. Each report is derived from a closed-door roundtable conducted by Aptitude Health. Roundtables are led by experts in the field of oncology, along with a clinical moderator. During a roundtable session, 10–15 community oncologists provide insights into the factors that drive their treatment decisions.

Each report provides key takeaways, an analysis of the discussion, and integrated polling. Reports also give an overview of the current disease landscape, as described by consulting physicians. CASES reports can be sorted by therapeutic topic and purchased as a bundle.
A CASES subscription delivers timely reports to your team throughout the year. There’s no need to spend time and money searching for the resources you need. Instead, your subscription delivers in-depth reports right to your inbox. Each report offers unique insight from practicing physicians and industry experts. View our 2020 CASES topics, summit schedule, and upcoming reports.

Therapeutic Area

Archives

Matthew Gordon

VP, Real-World Evidence
Matthew has more than 25 years of experience in real-world evidence and observational, non-interventional research. He has led studies across the full life cycle—from startup through publication—supporting objectives that range from understanding a disease’s natural history to fulfilling global safety surveillance requirements. Matthew brings deep expertise in orphan disease programs, having overseen more than 25 long-term, global initiatives, as well as in disease and product registries, prospective pharmacoeconomic studies, and systematic literature reviews. Matthew leads the RWE Registries team, responsible for building the business and team. Prior to joining Aptitude Health, he held senior leadership roles at Parexel, Worldwide Clinical Trials, inVentiv Health Clinical, Quintiles Outcome, and ICON Clinical Research. Matthew holds a BA in sociology from Boston University, is a long-standing member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and is a frequent speaker at ISPOR, the Center for Business Intelligence, and related industry conferences.

Gerald Stanvitch, PhD

VP, Scientific Content

Cate Browning, PhD

VP, Global Medical Affairs

Erin Zingales Rau

VP, Account Services

Kelly Kocor

VP, People & Culture
Kelly leads both the human resources and talent acquisition teams, ensuring that Aptitude Health attracts, retains, and develops top personnel to drive our continued success. With over 17 years of experience transforming global HR initiatives, Kelly is an expert in harmonizing HR policies and fostering a culture of engagement and partnership. She is committed to partnering with all areas of the business to ensure full regulatory compliance and delivering value-added services to our organization and its people. Kelly is passionate about developing and implementing HR strategies that help support our employees’ professional and personal growth. She is dedicated to fostering a culture that encourages innovation, collaboration, and inclusivity, helping Aptitude Health continue to be a great place to work.

Bart Zygmond

VP, Finance
Bart brings a wealth of experience to the organization, having worked in the life sciences, pharmaceuticals, manufacturing, and service industries. With his expertise in financial reporting, US GAAP, SOX, cash flow modeling, and financial analysis, he plays a crucial role in the company’s financial management and strategy. Prior to joining Aptitude Health as VP, Finance, Bart held several controller positions: at Q2 Solutions, he oversaw the global finance team and financial operations, ensuring the accurate and timely financial reporting of the company. He also held controller positions at Domtar Inc and Veristat.

Eugene Vissers, MD

Senior VP, Global Scientific Content
Eugene is a seasoned medical doctor with over 20 years of international experience in pharma, consultancy, and agency environments. Eugene leads the US team of dedicated experts responsible for developing high-quality medical content. Prior to joining Aptitude Health, Eugene served as medical director at Ipsen and AstraZeneca. With both his medical degree and an MBA, Eugene brings a unique perspective to his role. His clinical background, combined with his business acumen, allows him to develop innovative strategies that drive results. Under Eugene’s leadership, the medical content team delivers scientific information of the highest quality, providing valuable insights to our clients around the world.

Adrian Barfield

VP, US Business Development

Kelley Hernandez

Executive VP, US Business Development
Kelley has over 18 years of experience in the oncology space. Kelley joined Aptitude Health after working with Cardinal Health, where she was part of the Healthcare and Analytics Division, and finished her tenure there with VitalSource™ (GPO division). As the leader of the strategic business development team for the US, Kelley brings a wealth of expertise to the organization. Her experience in the healthcare industry, combined with her ability to identify and capitalize on new business opportunities, is invaluable in driving the company’s growth and success. Kelley’s dedication to building strong relationships with life science partners is a testament to her commitment to delivering exceptional value to the healthcare industry.

Adam Sinensky, MBA

Chief Technology Officer

Adam has over 20 years of experience in the healthcare industry and an MBA in healthcare management. After 10 years as a strategy consultant to life science companies, Adam has spent the last decade as a product and strategy leader focused on bringing technology products to market across the payor, provider, and life sciences segments. By combining his business acumen and experience working directly with software developers, engineers, and data scientists, Adam has successfully led numerous product launches and enhancements from ideation to development and go-to-market initiatives. His product and change management expertise has led organizational shifts from services to technology at companies such as Change Healthcare and Datavant/Ciox. At Aptitude Health, Adam is responsible for growing our portfolio of product offerings by leveraging real-world data and artificial intelligence with our existing solutions and industry-leading Axess Network of healthcare providers. He also oversees our IT and cybersecurity teams.

Stefanie Daniels

Chief Commercial Officer

Stefanie is a seasoned healthcare executive with over 20 years of experience in oncology. She brings a wealth of knowledge and expertise to the organization. Stefanie joined Aptitude Health after spending over a decade as a senior director at Physicians’ Education Resource, an oncology CME vendor. During her tenure, she led and managed teams responsible for grant development/acquisition, program creation/execution, and faculty management. Stefanie’s deep understanding of the oncology industry and her ability to lead teams through complex projects make her a vital part of the organization’s success. Her dedication to providing high-quality solutions to our life science partners is a testament to her commitment to improving cancer patient care.

Jason Cash

Chief Financial Officer

Jason is an accomplished finance professional with over 20 years of experience in the pharmaceutical services industry. Throughout his career, he has demonstrated a keen ability to navigate high-growth organizations, delivering exceptional results. Before joining Aptitude Health, Jason served as the CFO of Veristat International, a global contract research organization. In this role, he led the financial strategy and played a pivotal role in driving the company’s growth and success. Jason’s wealth of experience and expertise in financial management make him an essential member of the leadership team. His strategic thinking and ability to drive results are highly respected within the industry.

Jez Moulding

Chief Executive Officer
Jez is a seasoned leader with over 20 years of experience in general management and regional president roles. He has a proven track record of success in the healthcare industry, having worked in the US, Japan, Australia, Korea, South Africa, France, and the UK for Sanofi, where he supported the launch of 10 new drugs across various therapeutic areas. As chief commercial officer at UDG Healthcare and EVP at Ashfield, Jez demonstrated his expertise in developing and implementing successful business strategies. He joined Aptitude Health from Pharmaspectra, an IQVIA business, where he served as CEO since 2018. Jez’s extensive experience in the pharmaceutical industry and his leadership skills make him an invaluable asset to the organization.
Aptitude Health
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.